Erythromycin stearate Spofa--coated tablets for pediatric practice
Havlik, J.; Holý, M.
Ceskoslovenska Pediatrie 31(7): 402-404
1976
ISSN/ISBN: 0069-2328 PMID: 963828 Document Number: 103241
Document emailed within 1 workday
Related Documents
de Montalembert, M.; Bachir, D.; Hulin, A.; Gimeno, L.; Mogenet, Aès.; Bresson, J.Louis.; Macquin-Mavier, I.; Roudot-Thoraval, Fçoise.; Astier, A.; Galactéros, Fédéric. 2006: Pharmacokinetics of hydroxyurea 1,000 mg coated breakable tablets and 500 mg capsules in pediatric and adult patients with sickle cell disease Haematologica 91(12): 1685-1688Venho, V.M.; Palva, E.S.; Konno, K.; Stenfors, E. 1987: The value of comparative bioavailability studies of marketed drugs in drug control. An example with erythromycin stearate Methods and Findings in Experimental and Clinical Pharmacology 9(7): 445-447
Yamashita, T.; Tsubura, E. 1977: Influence of meal on the plasma concentration of patients received repeated administration of OE-7, erythromycin stearate capsules Japanese Journal of Antibiotics 30(7): 517-520
Iliaszenko, J.; Sokołowska, M.; Paruszewski, R. 2001: Gravimetric and spectrophotometric determination of some phenothiazine and imidazole derivatives in coated tablets and tablets Acta Poloniae Pharmaceutica 58(6): 411-413
Gupta, A. 1992: Use of medicines in pediatric practice: tablets vs liquids Indian Pediatrics 29(1): 122-124
Muzíková, J. 2002: Effect of magnesium stearate on the tensile strength of tablets made with the binder Prosolv SMCC 90 Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 51(1): 41-43
Spang, R. 1982: Breakability of tablets and film-coated dragees Pharmaceutica Acta Helvetiae 57(4): 99-111
Czarnecki, W.; Belniak, P. 2009: Tablets coated with the novel starch hydrolysate emulsion Acta Poloniae Pharmaceutica 66(4): 429-431
Garcia, Cássia.V.; Paim, Césio.S.; Steppe, M. 2004: New liquid chromatographic method for determination of rabeprazole sodium in coated tablets Journal - Association of Official Analytical Chemists 87(4): 842-846
Raghubanshi, R.S.; Jayaswal, S.B.; Singh, J. 1991: Controlled-release tablets of ethyl cellulose coated salbutamol sulphate microcapsules Die Pharmazie 46(2): 144-145
Chalabala, M.; Starha, L. 1970: Peroral, compounded long-acting drugs. 3. Tablets coated with Eudragite retard Ceskoslovenska Farmacie 19(5): 184-186
Tanamai, J.; Veeramanomai, S.; Indrakosas, N. 2004: The efficacy of cholesterol-lowering action and side effects of garlic enteric coated tablets in man Journal of the Medical Association of Thailand 87(10): 1156-1161
Rowe, R.C. 1982: The effect of pigment type and concentration on the incidence of edge splitting on film-coated tablets Pharmaceutica Acta Helvetiae 57(8): 221-225
Abrányi, I. 1988: Study on the effect of 150-mg Mydocalm coated tablets in peripheral vascular diseases and in myotonias of various origin Therapia Hungarica 36(2): 56-61
Hoblitzell, J.R.; Thakker, K.D.; Rhodes, C.T. 1985: Effects of moderate stress storage conditions on the dissolution profile of enteric-coated aspirin tablets Pharmaceutica Acta Helvetiae 60(1): 28-32
Chalabala, M.; Starha, L.; Muzik, M. 1972: Peroral long-acting drugs. VII. Tablets prepared of a granulated powder coated with fatty acids Ceskoslovenska Farmacie 21(4): 153-155
Delonca, H.; Puech, A.; Segura, G.; Joachim, J. 1972: Influence of excipients and storage conditions on drug preservation. 3. Coated tablets with acetylsalicylic acid base Journal de Pharmacie de Belgique 27(1): 40-49
Korsatko-Wabnegg, B. 1990: Development of press-coated tablets with controlled-release effect with a base of poly-d(-)-3-hydroxybutyric acid Die Pharmazie 45(11): 842-844
Xu, M.; Yuan, Q.; Zhao, H.; Li, F.; Hu, X.-L.; Fu, Y.-Y.; Shi, G.-H.; Wang, X.-M.; Zhang, N. 2013: Determination of chlorogenic acid and baicalin in Yinhuang film-coated tablets by HPLC isocratic elution Zhongguo Zhong Yao Za Zhi 38(5): 691-693
Dévay, A.; Rácz, I. 1986: Factorial pilot project for the optimization of technological parameters of film coating in the manufacturing process. I. Laboratory manufacture of enteric-coated tablets and their analysis Acta Pharmaceutica Hungarica 56(5): 227-231